|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
JPH02306947A
(ja)
|
1989-05-01 |
1990-12-20 |
Monsanto Co |
キラルβ―アミノ酸の製造方法
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
DK0578728T3
(da)
|
1991-04-05 |
1999-04-12 |
Genentech Inc |
Inhibitorer for aggregering af blodplader, hvilke inhibitorer har høj specificitet for GP IIbIIIa
|
|
US5569741A
(en)
|
1992-07-27 |
1996-10-29 |
Biomeasure, Inc. |
Cyclic octapeptide neuromedin B receptor antagonists
|
|
DK0644772T3
(da)
|
1992-11-12 |
2003-06-30 |
Sod Conseils Rech Applic |
Opioid-peptider
|
|
US5293050A
(en)
|
1993-03-25 |
1994-03-08 |
International Business Machines Corporation |
Semiconductor quantum dot light emitting/detecting devices
|
|
AU673731B2
(en)
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
GB9516994D0
(en)
|
1995-08-18 |
1995-10-18 |
Iaf Biochem Int |
Solution synthesis of peripheral acting analgestic opioid tetrapeptides
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
US5993811A
(en)
|
1997-02-03 |
1999-11-30 |
Biology Associates, Llc |
Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
|
|
CA2206028C
(en)
|
1997-06-04 |
2006-10-03 |
Frantisek Ziak |
Fitness-balance board
|
|
JP2001509493A
(ja)
|
1997-07-11 |
2001-07-24 |
インナーダイン， インコーポレイテッド |
放射送達構造体の調製およびシール化のための方法およびシステム
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
JP2001523711A
(ja)
|
1997-11-24 |
2001-11-27 |
メルク エンド カムパニー インコーポレーテッド |
細胞接着阻害薬としての環状アミノ酸誘導体
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
WO2000006243A2
(en)
|
1998-07-28 |
2000-02-10 |
Innerdyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
|
JP2002522063A
(ja)
|
1998-08-17 |
2002-07-23 |
アブジェニックス インコーポレイテッド |
増加した血清半減期を有する改変された分子の生成
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
CA2361830A1
(en)
|
1999-03-17 |
2000-09-21 |
Novo Nordisk A/S |
Method for acylating peptides and novel acylating agents
|
|
MXPA01010231A
(es)
|
1999-04-12 |
2003-07-21 |
Aventis Pharma Ltd |
Compuestos heteroarilo biciclicos sustituidos como antagonistas de integrina.
|
|
WO2001068586A2
(en)
|
2000-03-14 |
2001-09-20 |
Novartis Ag |
α4β1 AND α4β7 INTEGRIN INHIBITORS
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
CA2436326C
(en)
|
2001-01-09 |
2012-08-14 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
JP2005533855A
(ja)
|
2002-07-24 |
2005-11-10 |
インターツェル・アクチェンゲゼルシャフト |
病原性ウイルスからの別のリーディングフレームによりコードされる抗原
|
|
US20040176293A1
(en)
|
2002-12-18 |
2004-09-09 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
EP1618131A2
(en)
|
2003-04-15 |
2006-01-25 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
EP1680443B9
(en)
|
2003-11-05 |
2014-09-03 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides and uses thereof
|
|
US20060030053A1
(en)
|
2003-12-19 |
2006-02-09 |
Applera Corporation |
Methods and systems for protein and peptide evidence assembly
|
|
DOP2005000002A
(es)
|
2004-01-09 |
2005-08-15 |
Pfizer |
"anticuerpos contra madcam"
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
NZ551934A
(en)
|
2004-06-24 |
2009-09-25 |
Inst Medical W & E Hall |
Conjugates comprising a targeting moiety and a peptide that mimics the apoptosis-inducing BH3-only proteins
|
|
NZ554331A
(en)
|
2004-09-23 |
2009-04-30 |
Univ Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
US20080300180A1
(en)
|
2004-11-30 |
2008-12-04 |
Gastrotech Pharma A/S |
Growth Hormone Secretagogue Receptor 1A Ligands
|
|
DK1831699T3
(da)
|
2004-12-20 |
2010-03-15 |
Antibodyshop As |
Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
CA2549477A1
(en)
|
2005-06-29 |
2006-12-29 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin
|
|
AU2006294644A1
(en)
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
TW200744634A
(en)
*
|
2006-02-21 |
2007-12-16 |
Wyeth Corp |
Methods of using antibodies against human IL-22
|
|
WO2007120883A2
(en)
|
2006-04-12 |
2007-10-25 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
EP2024509A4
(en)
|
2006-05-22 |
2010-08-04 |
Clinical Genomics Pty Ltd |
DETECTION METHOD
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
JP2009540018A
(ja)
*
|
2006-06-13 |
2009-11-19 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
KR101399175B1
(ko)
|
2006-07-21 |
2014-06-19 |
푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 |
항염증성 및 항알레르기성 시클릭 펩티드
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
WO2008140602A2
(en)
|
2006-12-07 |
2008-11-20 |
The Govenment Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services |
USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN
|
|
PE20130588A1
(es)
|
2007-02-02 |
2013-05-21 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
|
NZ578948A
(en)
|
2007-02-15 |
2012-03-30 |
Univ Indiana Res & Tech Corp |
Glucagon/glp-1 receptor co-agonists
|
|
HUE042172T2
(hu)
|
2007-02-23 |
2019-06-28 |
Merck Sharp & Dohme |
Genetikailag elõállított anti-il-23P19 antitestek
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
ES2465223T3
(es)
*
|
2007-04-27 |
2014-06-05 |
Zymogenetics, Inc. |
Antagonistas de IL-17A, IL-17F e IL-23P19 y procedimientos de uso
|
|
US8313950B2
(en)
|
2007-05-21 |
2012-11-20 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
WO2009002947A2
(en)
|
2007-06-22 |
2008-12-31 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
JP2011501941A
(ja)
|
2007-07-06 |
2011-01-20 |
バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ |
Ｉｌ−２３レセプターのアンタゴニストおよびその使用
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
US20100280098A1
(en)
|
2007-10-05 |
2010-11-04 |
Juliano Rudolph L |
Receptor targeted oligonucleotides
|
|
EP2352762A1
(en)
|
2008-11-03 |
2011-08-10 |
Schering Corporation |
Inflammatory bowel disease biomarkers and related methods of treatment
|
|
WO2010065815A2
(en)
|
2008-12-05 |
2010-06-10 |
The Regents Of The University Of California |
Mini-hepcidin peptides and methods of using thereof
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
ES2525179T3
(es)
|
2009-04-08 |
2014-12-18 |
Takeda Pharmaceutical Company Limited |
Derivado de neuromedina U
|
|
TWI578992B
(zh)
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
US20110142889A1
(en)
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
CA2787331A1
(en)
|
2010-01-25 |
2011-07-28 |
Hazel H. Szeto |
Aromatic-cationic peptides and uses of same
|
|
US9523073B2
(en)
*
|
2010-03-31 |
2016-12-20 |
Medical Diagnostic Laboratories, Llc |
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
US20130236977A1
(en)
|
2010-05-24 |
2013-09-12 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
IT1406051B1
(it)
|
2010-08-05 |
2014-02-06 |
D M G Italia S R L |
Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
|
|
ES2763404T3
(es)
|
2010-08-11 |
2020-05-28 |
Ironwood Pharmaceuticals Inc |
Formulaciones estables de linaclotida
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
WO2012101599A2
(en)
|
2011-01-27 |
2012-08-02 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US8946150B2
(en)
*
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
CA2839408A1
(en)
|
2011-06-14 |
2012-12-20 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9169292B2
(en)
*
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
BR112014013697A2
(pt)
|
2011-12-09 |
2020-11-03 |
The Regents Of The University Of California |
peptídeos mini-hepcidina modificados e métodos de uso dos mesmos
|
|
WO2013177432A1
(en)
|
2012-05-23 |
2013-11-28 |
The University Of Chicago |
Methods of treating obesity
|
|
US9024044B2
(en)
|
2012-06-14 |
2015-05-05 |
Ajinomoto Co., Inc. |
Heteroarylcarboxylic acid ester derivative
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
EP2956154A4
(en)
|
2013-02-15 |
2016-07-27 |
Srx Cardio Llc |
TYPE 9 (PCSK9) PROPYTEIN CONVERTASE SUBTILISINE / KEXINE PROPAGINE CONVERTASE BINDING LIGANDS FOR USE IN MODULATION OF SERIES LEVELS OF LOW DENSITY LIPOPROTEIN (LDL)
|
|
EP4091624A1
(en)
|
2013-03-15 |
2022-11-23 |
Protagonist Therapeutics, Inc. |
Hepcidin analogues and uses thereof
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
PT3013351T
(pt)
|
2013-06-24 |
2020-01-17 |
Canbas Co Ltd |
Péptidos e peptidomiméticos em utilizações e tratamentos combinados para subpopulações de pacientes com cancro
|
|
CA2916492A1
(en)
|
2013-06-27 |
2014-12-31 |
Stealth Biotherapeutics Corp |
Peptide therapeutics and methods for using same
|
|
JP2016534043A
(ja)
|
2013-10-09 |
2016-11-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
炎症促進性サイトカインのダウンレギュレーションに有用なグアニル酸シクラーゼのアゴニスト
|
|
WO2015112700A1
(en)
|
2014-01-22 |
2015-07-30 |
Wisconsin Alumni Research Foundation |
Alpha/beta-peptide mimics of z-domain peptides
|
|
KR20170002414A
(ko)
|
2014-04-07 |
2017-01-06 |
멀겐져 바이오텍, 아이엔씨. |
헵시딘 모방 펩티드 및 그 용도
|
|
CA2949215C
(en)
|
2014-05-16 |
2023-03-14 |
Protagonist Therapeutics, Inc. |
.alpha.4.beta.7 integrin thioether peptide antagonists
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
AU2015279571A1
(en)
|
2014-06-27 |
2017-02-02 |
Protagonist Therapeutics, Inc. |
Hepcidin and mini-hepcidin analogues and uses therof
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
SG10201810154WA
(en)
|
2014-07-17 |
2018-12-28 |
Protagonist Therapeutics Inc |
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
|
|
JP2017535527A
(ja)
|
2014-10-01 |
2017-11-30 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
新規のα４β７ペプチド単量体及び二量体拮抗薬
|
|
WO2016054445A1
(en)
|
2014-10-01 |
2016-04-07 |
Protagonist Therapeutics, Inc. |
Novel cyclic monomer and dimer peptides having integrin antagonist activity
|
|
WO2016109363A1
(en)
|
2014-12-29 |
2016-07-07 |
The Regents Of The University Of California |
S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
WO2016115168A1
(en)
|
2015-01-12 |
2016-07-21 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
HK1257747A1
(zh)
|
2015-07-15 |
2019-10-25 |
Protagonist Therapeutics Inc. |
白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CA3009834A1
(en)
|
2015-12-30 |
2017-07-06 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
CA3017926C
(en)
|
2016-03-23 |
2023-10-10 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .alpha.4.beta.7 peptide antagonists
|
|
WO2018022937A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
US20190264197A1
(en)
|
2016-07-27 |
2019-08-29 |
Protagonist Therapeutics, Inc. |
Disulfide-rich peptide libraries and methods of use thereof
|
|
US20200064357A1
(en)
|
2016-11-09 |
2020-02-27 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
CA3046171A1
(en)
|
2016-12-06 |
2018-06-14 |
Stichting Voor De Technische Wetenschappen |
Multicyclic peptides and methods for their preparation
|
|
JP2020505352A
(ja)
|
2017-01-18 |
2020-02-20 |
プロタゴニスト セラピューティクス， インコーポレイテッド |
インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用
|
|
EP3681900A4
(en)
|
2017-09-11 |
2021-09-08 |
Protagonist Therapeutics, Inc. |
OPIOID AGONIST PEPTIDES AND THEIR USES
|
|
WO2019157268A1
(en)
|
2018-02-08 |
2019-08-15 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
US12171764B2
(en)
*
|
2018-06-20 |
2024-12-24 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
|
|
KR20250161677A
(ko)
|
2018-06-21 |
2025-11-17 |
머크 샤프 앤드 돔 엘엘씨 |
Pcsk9 길항제 화합물
|
|
CA3104418A1
(en)
|
2018-07-12 |
2020-01-16 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
CA3135024A1
(en)
|
2019-03-28 |
2020-10-01 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .beta.-homoamino acids
|
|
AU2020311395A1
(en)
|
2019-07-10 |
2022-02-03 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
US20220372099A1
(en)
|
2019-09-03 |
2022-11-24 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
EP4093421A4
(en)
|
2020-01-10 |
2024-01-10 |
Protagonist Therapeutics, Inc. |
Methods for treating inflammatory bowel diseases with alpha4beta7 integrin antagonists
|
|
SMT202500254T1
(it)
|
2020-01-15 |
2025-09-12 |
Janssen Biotech Inc |
Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie
|
|
MX2022008740A
(es)
|
2020-01-15 |
2022-09-23 |
Janssen Biotech Inc |
Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
|
|
WO2021146458A1
(en)
|
2020-01-15 |
2021-07-22 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
IL299530A
(en)
|
2020-07-28 |
2023-02-01 |
Protagonist Therapeutics Inc |
Psidine is a conjugated mimetic
|
|
AU2021383828A1
(en)
|
2020-11-20 |
2023-07-06 |
Janssen Pharmaceutica Nv |
Compositions of peptide inhibitors of interleukin-23 receptor
|
|
EP4314014A4
(en)
|
2021-04-01 |
2025-03-05 |
Protagonist Therapeutics, Inc. |
HEPCIDIN MIMETICS CONJUGATES
|
|
WO2022212696A1
(en)
|
2021-04-01 |
2022-10-06 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2022212698A1
(en)
|
2021-04-01 |
2022-10-06 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
CA3220871A1
(en)
|
2021-06-14 |
2022-12-22 |
Protagonist Therapeutics, Inc. |
Hepcidin mimetics for treatment of hereditary hemochromatosis
|
|
KR20240034224A
(ko)
|
2021-07-14 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
인터류킨-23 수용체의 지질화된 펩티드 억제제
|
|
CA3226539A1
(en)
|
2021-07-14 |
2023-01-19 |
Janssen Biotech, Inc. |
Peptide inhibitors of interleukin-23 receptor
|
|
JP2024525723A
(ja)
|
2021-07-14 |
2024-07-12 |
ヤンセン バイオテツク，インコーポレーテツド |
インターロイキン－２３受容体の二環式ペプチド阻害剤
|